Salvat: Clinical Trials

11 completed, 1 unknown. 10 Phase 3, 2 Phase 2.

By phase and status

Phase	Trials	Status
Phase 3	10	Completed 9, Unknown 1
Phase 2	2	Completed 2

Follow Salvat: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Clobetasol Propionate Ophthalmic Nanoemulsion, 0.05% in the Treatment of Inflammation After Cataract Surgery in Pediatric Population Clobetasol Propionate, Prednisolone acetate ophthalmic suspension, 1% - Cataracts Infantile	Phase 3	Unknown	Salvat	60	2022-12-12	2024-09-27
Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-1) Clobetasol propionate, Vehicle - Cataract	Phase 3	Completed	Salvat	250	2020-06-10	2022-12-22
SVT-15652 Otic Solution for the Treatment of Otomycosis. SVT-15652, Placebo - Otomycosis	Phase 3	Completed	Salvat	194	2020-06-09	2022-12-15
Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-2) Clobetasol Propionate, Vehicle - Cataract	Phase 3	Completed	Salvat	215	2020-06-04	2022-12-22
SVT-15652 Otic Solution for the Treatment of Otomycosis SVT-15652, Placebo - Otomycosis	Phase 3	Completed	Salvat	217	2020-02-27	2024-12-03
Efficacy and Safety of DF289 Plus DF277 Otic Solution in the Treatment of Acute Otitis Externa DF289 plus DF277, DF289, DF277 - Acute Otitis Externa	Phase 3	Completed	Salvat	493	2017-07-22	2021-04-09
A Clinical Trial to Assess the Effect of HC-SVT-1001 and HC-SVT-1002 in the Surgical Treatment of Atrophic Pseudarthrosis of Long Bones (Bonecure) HC-SVT-1001(initial protocol); HC-SVT-1002 (protocol amendment) - Pseudoarthrosis	Phase 2	Completed	Salvat	12	2015-11-10	2021-03-17
Clinical Study to Assess the Efficacy and Safety of G238 Compared to Clotrimazole Otic Solution in the Treatment of Otomycosis G238, Clotrimazole - Otomycosis	Phase 3	Completed	Salvat	190	2013-05-01	2017-04-04
Clinical Study to Assess the Efficacy and Safety of DF277 Compared to Placebo in the Treatment of Otic Eczema DF277, Placebo - Otic Eczema	Phase 3	Completed	Salvat	135	2012-02-01	2017-05-30
Efficacy and Safety of DF289 Plus DF277 Otic Solution in the Treatment of Middle Ear Infections in Pediatric Patients DF289, DF277, DF289 plus DF277 - Acute Otitis Media	Phase 3	Completed	Salvat	331	2011-06-01	2017-10-04
Clinical Study to Assess the Efficacy and Safety of DF289 Plus DF277 Otic Solution in the Treatment of Middle Ear Infections in Pediatric Patients DF289, DF277, DF289 plus DF277 - Acute Otitis Media	Phase 3	Completed	Salvat	331	2011-06-01	2015-10-22
SVT-40776 in Patients Suffering From Overactive Bladder Syndrome SVT-40776 - Overactive Bladder (OAB)	Phase 2	Completed	Salvat		2006-09-01	2011-06-08

Conditions studied

Inflammation (3)  ·  Otomycosis (3)  ·  Pain (3)  ·  Cataract (2)  ·  Otitis Media (2)  ·  Pseudarthrosis (1)  ·  Urinary Bladder, Overactive (1)

Interventions

Clobetasol (3)  ·  Adrenal Cortex Hormones (1)  ·  Anti-Bacterial Agents (1)  ·  Clinical Protocols (1)  ·  Clotrimazole (1)  ·  SVT-40776 (1)

Countries

Spain (8)  ·  United States (3)

Top investigators

Andrew Schwartz, MD (2)  ·  Enrique Jimenez, MD (1)

Results publications

PMID 12424394, PMID 14977340, PMID 24935281, PMID 27810317, PMID 28006041, PMID 28670710, PMID 42192627, PMID 34033120, PMID 35834251, PMID 38789992